Comment on CMS-2026-1255-0001
Center for Medicare AdvocacySupportAdvocacy
Summary: The Center for Medicare Advocacy (CMA) supports the proposal to require specific reasons for drug denial but urges CMS to require even greater detail, plain language, and standardized templates for these notices. They also express concern regarding potential administrative burdens for patients and suggest specific processes to improve access to durable medical equipment for dually eligible individuals.
See attached file(s)